Evidence map›Paper›PMID 25319827›Full record

ArticleGenes & development2014

A gene-specific role for the Ssu72 RNAPII CTD phosphatase in HIV-1 Tat transactivation.

Yupeng Chen, Lirong Zhang, Conchi Estarás, Seung H Choi, Luis Moreno, Jonathan Karn, James J Moresco, John R Yates, Katherine A Jones

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Ssu72 Dual-Specific Protein Phosphatase: From Gene to Diseases.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yupeng ChenRegulatory Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA;
Lirong ZhangRegulatory Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA;
Conchi EstarásRegulatory Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA;
Seung H ChoiRegulatory Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA;
Luis MorenoRegulatory Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA;
Jonathan KarnDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA;
James J MorescoDepartment of Chemical Physiology and Cell Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
John R YatesDepartment of Chemical Physiology and Cell Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
Katherine A JonesRegulatory Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA; jones@salk.edu.
Salk Institute for Biological Studies · USScripps Research Institute · USCase Western Reserve University · US

Funding

Using NK Cells to eliminate the latent HIV reservoirU19AI096113 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CLEMENTS, JANICE E · 2011 to 2015
$39.5M
ZDS2P REGULATES SWE1P-DEPENDENT POLARIZED CELL GROWTH IN S CEREVISIAEP41RR011823 · NCRR · UNIVERSITY OF WASHINGTON · PI FIELDS, STANLEY · 1996 to 2011
$24.7M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI RIFFLE, MICHAEL · 2012 to 2021
$20.7M
CYCLIN T AND HIV1 TAT TRANSACTIVATIONR01AI044615 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI JONES, KATHERINE A · 1999 to 2016
$6.9M
Manipulating Epigenetic Control Mechanisms to Control HIV TranscriptionDP1DA028869 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN · 2009 to 2013
$3.9M
Cyclin T and HIV1 Tat TransactivationR56AI044615 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI JONES, KATHERINE A · 2009 to 2009
$474k
NCRR NIH HHS 5P41RR011823NCRR NIH HHS P41 RR011823NIAID NIH HHS AI044615NIAID NIH HHS R01 AI044615NIAID NIH HHS R56 AI044615NIAID NIH HHS U19 AI096113NIAID NIH HHS U19-AI096113NIDA NIH HHS DP1 DA028869NIDA NIH HHS DP1-DA028869NIGMS NIH HHS GM103533NIGMS NIH HHS P41 GM103533
6 · The paper itself

Abstract

HIV-1 Tat stimulates transcription elongation by recruiting the P-TEFb (positive transcription elongation factor-b) (CycT1:CDK9) C-terminal domain (CTD) kinase to the HIV-1 promoter. Here we show that Tat transactivation also requires the Ssu72 CTD Ser5P (S5P)-specific phosphatase, which mediates transcription termination and intragenic looping at eukaryotic genes. Importantly, HIV-1 Tat interacts directly with Ssu72 and strongly stimulates its CTD phosphatase activity. We found that Ssu72 is essential for Tat:P-TEFb-mediated phosphorylation of the S5P-CTD in vitro. Interestingly, Ssu72 also stimulates nascent HIV-1 transcription in a phosphatase-dependent manner in vivo. Chromatin immunoprecipitation (ChIP) experiments reveal that Ssu72, like P-TEFb and AFF4, is recruited by Tat to the integrated HIV-1 proviral promoter in TNF-α signaling 2D10 T cells and leaves the elongation complex prior to the termination site. ChIP-seq (ChIP combined with deep sequencing) and GRO-seq (genome-wide nuclear run-on [GRO] combined with deep sequencing) analysis further reveals that Ssu72 predominantly colocalizes with S5P-RNAPII (RNA polymerase II) at promoters in human embryonic stem cells, with a minor peak in the terminator region. A few genes, like NANOG, also have high Ssu72 at the terminator. Ssu72 is not required for transcription at most cellular genes but has a modest effect on cotranscriptional termination. We conclude that Tat alters the cellular function of Ssu72 to stimulate viral gene expression and facilitate the early S5P-S2P transition at the integrated HIV-1 promoter.

Indexed as

Transcriptional ActivationCarrier ProteinsEmbryonic Stem CellsHIV-1HumansPhosphoprotein PhosphatasesPromoter Regions, Genetictat Gene Products, Human Immunodeficiency VirusT-LymphocytesCarrier ProteinsPhosphoprotein PhosphatasesSSU72 protein, humantat Gene Products, Human Immunodeficiency VirusCTD phosphataseelongationHIV-1 TatSsu72

Identifiers

PMID25319827
PMCPMC4201287
OpenAlexW1995398137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.